Key Events This Week
23 Feb: Significant open interest surge signalling bullish positioning
25 Feb: New 52-week high of Rs.2,270.4 achieved
26 Feb: Fresh 52-week high of Rs.2,331.2 recorded
27 Feb: New 52-week high of Rs.2,336 reached despite minor pullback
23 February 2026: Surge in Open Interest Signals Bullish Market Positioning
On Monday, Lupin Ltd saw a notable 13.07% increase in open interest in its derivatives segment, rising from 34,999 to 39,574 contracts. This surge accompanied a 1.14% rise in the stock price to Rs.2,245.10, outperforming the Sensex’s 0.39% gain. The futures segment alone accounted for a notional value of approximately ₹1,24,793 lakhs, while options trading reached ₹18,036.28 crores, highlighting strong market participation.
The stock traded near its 52-week high, supported by positive technical indicators with prices above all key moving averages. However, delivery volumes declined by 27.56% compared to the 5-day average, suggesting some speculative positioning rather than outright accumulation. Despite this, the overall derivatives activity pointed to fresh bullish bets, reflecting confidence in Lupin’s growth prospects within the Pharmaceuticals & Biotechnology sector.
Quarter after quarter, this Small Cap from the Lifestyle sector delivers without fail! Just added to our Reliable Performers with proven staying power. Stability meets growth here beautifully.
- - Consistent quarterly delivery
- - Proven staying power
- - Stability with growth
25 February 2026: Lupin Hits New 52-Week High of Rs.2,270.4
Midweek, Lupin Ltd reached a fresh 52-week high of Rs.2,270.4, marking a continuation of its upward momentum. The stock gained 1.84% on the day, closing well above all major moving averages, signalling a sustained uptrend. This performance outpaced the Pharmaceuticals & Biotechnology sector’s 0.50% gain and the Sensex’s 0.41% rise.
Financially, Lupin’s fundamentals remain strong with net sales growing at 11.42% annually and operating profit margins at 33.60%. The company reported a profit before tax excluding other income of Rs.1,833.91 crores for the latest quarter, a 43.6% increase over the previous four-quarter average. Institutional investors hold a significant 47.08% stake, underscoring confidence in the company’s prospects.
26 February 2026: New 52-Week High of Rs.2,331.2 Reinforces Uptrend
Lupin Ltd extended its rally on Thursday, hitting a new 52-week high of Rs.2,331.2, a 1.34% gain on the day. This marked the fourth consecutive day of gains, delivering a cumulative 4.7% return over this period. The stock’s price remained comfortably above all key moving averages, reflecting strong technical momentum despite a broadly mixed market.
The company’s robust financial metrics, including a return on capital employed of 22.22% and return on equity of 22%, support the stock’s valuation. Lupin’s price-to-book ratio of 5.3 and PEG ratio of 0.3 indicate that earnings growth underpins the price appreciation. The stock’s total return over the past year stands at 22.60%, more than double the Sensex’s 10.54% gain.
Lupin Ltd. caught your attention? Explore our comprehensive research report with in-depth analysis of this mid-cap stock – fundamentals, valuations, financials, and technical outlook!
- - Comprehensive research report
- - In-depth mid-cap analysis
- - Valuation assessment included
27 February 2026: Lupin Reaches Rs.2,336 Despite Minor Pullback
On Friday, Lupin Ltd touched a new 52-week high of Rs.2,336, although the stock closed slightly lower by 0.94% at Rs.2,301.35. This minor pullback followed four consecutive days of gains and occurred amid a broader market decline, with the Sensex falling 1.16%. Despite the dip, Lupin remained above all major moving averages, maintaining its strong technical position.
The company’s financial strength remains evident with consistent quarterly earnings growth, a low debt-to-equity ratio of 0.10, and a high institutional ownership of 47.08%. Lupin’s Mojo Score of 78.0 and a Buy grade from MarketsMOJO reflect its solid fundamentals and market standing. The stock’s 31.6% appreciation from its 52-week low of Rs.1,774 highlights its resilience and sustained investor interest.
Key Takeaways
- Strong weekly gain of 3.68% outpacing the Sensex’s 0.96% decline
- Multiple new 52-week highs reached, signalling robust momentum
- Significant surge in derivatives open interest indicating bullish market positioning
- Solid financial metrics including 22.22% ROCE and 22% ROE
- High institutional ownership at 47.08%, reflecting confidence
- Minor pullback on final day amid broader market weakness, but trend intact
Weekly Price Performance: Lupin Ltd vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-02-23 | Rs.2,245.10 | +1.14% | 36,817.86 | +0.39% |
| 2026-02-24 | Rs.2,251.10 | +0.27% | 36,530.09 | -0.78% |
| 2026-02-25 | Rs.2,292.45 | +1.84% | 36,679.75 | +0.41% |
| 2026-02-26 | Rs.2,323.20 | +1.34% | 36,748.49 | +0.19% |
| 2026-02-27 | Rs.2,301.35 | -0.94% | 36,322.56 | -1.16% |
Conclusion
Lupin Ltd’s performance over the week ending 27 February 2026 was marked by strong gains and multiple new 52-week highs, underscoring the stock’s robust momentum amid a mixed market environment. The significant rise in derivatives open interest early in the week signalled bullish positioning, which was validated by consistent price appreciation and solid financial results. Despite a minor pullback on the final trading day, Lupin’s position above key moving averages and its attractive valuation metrics support the continuation of its positive trend.
Institutional backing remains strong, and the company’s consistent earnings growth and prudent financial management provide a solid foundation for sustained performance. Lupin’s Mojo Score of 78.0 and Buy rating reflect its quality and market standing. Investors should note the stock’s resilience relative to the broader market and sector peers, making it a noteworthy contender in the Pharmaceuticals & Biotechnology space.
Limited Period Only. Start at Rs. 9,999 - Get MojoOne for 1 Year + 3 Months FREE (60% Off) Get 71% Off →
